BS
Banco Santander Portfolio holdings
AUM
$10.5B
This Quarter Return
+5.37%
1 Year Return
+20.99%
3 Year Return
+68.54%
5 Year Return
+212.19%
10 Year Return
–
AUM
$8.76B
AUM Growth
+$8.76B
(+2.1%)
Cap. Flow
-$252M
Cap. Flow
% of AUM
-2.88%
Top 10 Holdings %
Top 10 Hldgs %
67.21%
Holding
442
New
65
Increased
109
Reduced
150
Closed
87
Top Buys
| 1 |
American Electric Power
AEP
|
$45.2M |
| 2 |
Amazon
AMZN
|
$38.7M |
| 3 |
ConocoPhillips
COP
|
$36.2M |
| 4 |
Coca-Cola
KO
|
$28.1M |
| 5 |
Biogen
BIIB
|
$27.5M |
Top Sells
| 1 |
iShares Floating Rate Bond ETF
FLOT
|
$91.7M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$67M |
| 3 |
Cigna
CI
|
$51.6M |
| 4 |
Citigroup
C
|
$49.8M |
| 5 |
Citizens Financial Group
CFG
|
$48.4M |
Sector Composition
| 1 | Financials | 60.8% |
| 2 | Healthcare | 6.81% |
| 3 | Technology | 4.07% |
| 4 | Communication Services | 2.97% |
| 5 | Consumer Discretionary | 2.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Qualcomm
QCOM
$168B
| $1.95M | 0.02% |
+27,019
| New | +$1.95M |
|
|
PFPT
202
DELISTED
Proofpoint, Inc.
PFPT
| $1.94M | 0.02% |
+18,220
| New | +$1.94M |
|
203
Regeneron Pharmaceuticals
REGN
$61.9B
| $1.9M | 0.02% |
4,700
-12,100
| -72% | -$4.89M |
|
204
Royal Caribbean
RCL
$96.2B
| $1.87M | 0.02% |
14,419
-1,323
| -8% | -$172K |
|
205
iShares MSCI Hong Kong ETF
EWH
$709M
| $1.86M | 0.02% |
77,800
| – | – |
|
206
iShares Core S&P Mid-Cap ETF
IJH
$98.9B
| $1.84M | 0.02% |
9,130
+1,490
| +20% | +$300K |
|
207
iShares MSCI Canada ETF
EWC
$3.17B
| $1.74M | 0.02% |
60,550
-13,318
| -18% | -$384K |
|
208
AbbVie
ABBV
$373B
| $1.73M | 0.02% |
18,257
+1,178
| +7% | +$111K |
|
209
Expeditors International
EXPD
$16.3B
| $1.67M | 0.02% |
+22,662
| New | +$1.67M |
|
210
Estee Lauder
EL
$32.7B
| $1.65M | 0.02% |
11,349
+2,608
| +30% | +$379K |
|
211
iShares MSCI USA Min Vol Factor ETF
USMV
$23.4B
| $1.65M | 0.02% |
28,894
-4
| -0% | -$228 |
|
212
AstraZeneca
AZN
$249B
| $1.64M | 0.02% |
41,530
-4,420
| -10% | -$175K |
|
213
Unilever
UL
$156B
| $1.54M | 0.02% |
28,050
-1,960
| -7% | -$108K |
|
214
Telefonica
TEF
$30.1B
| $1.52M | 0.02% |
193,456
| – | – |
|
215
Novo Nordisk
NVO
$252B
| $1.51M | 0.02% |
+32,100
| New | +$1.51M |
|
216
Philip Morris
PM
$258B
| $1.51M | 0.02% |
18,501
+11,890
| +180% | +$969K |
|
217
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$29.2B
| $1.5M | 0.02% |
13,060
+1,400
| +12% | +$161K |
|
218
PepsiCo
PEP
$213B
| $1.47M | 0.02% |
13,113
-8,863
| -40% | -$991K |
|
219
Xtrackers MSCI Japan Hedged Equity ETF
DBJP
$392M
| $1.44M | 0.02% |
32,349
-6,476
| -17% | -$288K |
|
220
GSK
GSK
$79.5B
| $1.44M | 0.02% |
35,720
-7,470
| -17% | -$300K |
|
221
SEI Investments
SEIC
$10.7B
| $1.43M | 0.02% |
+23,330
| New | +$1.43M |
|
222
iShare MSCI Eurozone ETF
EZU
$7.74B
| $1.39M | 0.02% |
33,844
+21,220
| +168% | +$870K |
|
223
Chubb
CB
$110B
| $1.37M | 0.02% |
10,249
-795
| -7% | -$106K |
|
224
Barclays
BCS
$67.9B
| $1.33M | 0.02% |
148,980
+1,981
| +1% | +$17.7K |
|
225
Intuit
INTU
$184B
| $1.33M | 0.02% |
5,854
+3,690
| +171% | +$839K |
|